These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16304359)

  • 1. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
    Gladwin MT; Kato GJ
    Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.
    Lin EE; Rodgers GP; Gladwin MT
    Curr Hematol Rep; 2005 Mar; 4(2):117-25. PubMed ID: 15720960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
    Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
    Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular hemolysis and the pathophysiology of sickle cell disease.
    Kato GJ; Steinberg MH; Gladwin MT
    J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in chronic hemolytic anemias: Pathophysiology and treatment.
    Haw A; Palevsky HI
    Respir Med; 2018 Apr; 137():191-200. PubMed ID: 29605204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
    Wood KC; Hsu LL; Gladwin MT
    Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell disease at the dawn of the molecular era.
    Abboud MR; Musallam KM
    Hemoglobin; 2009; 33 Suppl 1():S93-S106. PubMed ID: 20001639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of vasculopathy in sickle cell disease and thalassemia.
    Morris CR
    Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
    Kato GJ; Gladwin MT
    JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
    Yates AM; Joshi VM; Aygun B; Moen J; Smeltzer MP; Govindaswamy D; Dowdy J; Cotton A; Kang G; Ware RE; Hankins JS
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27717. PubMed ID: 30907497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in clinical research in sickle cell disease.
    Hagar W; Vichinsky E
    Br J Haematol; 2008 May; 141(3):346-56. PubMed ID: 18341629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.
    Hanson MS; Xu H; Flewelen TC; Holzhauer SL; Retherford D; Jones DW; Frei AC; Pritchard KA; Hillery CA; Hogg N; Wandersee NJ
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H328-36. PubMed ID: 23125208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic anemia.
    Dhaliwal G; Cornett PA; Tierney LM
    Am Fam Physician; 2004 Jun; 69(11):2599-606. PubMed ID: 15202694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic anemias due to hemoglobinopathies.
    Poyart C; Wajcman H
    Mol Aspects Med; 1996 Apr; 17(2):129-42. PubMed ID: 8813715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.
    Kato GJ; Gladwin MT; Steinberg MH
    Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priapism in sickle-cell disease: a hematologist's perspective.
    Kato GJ
    J Sex Med; 2012 Jan; 9(1):70-8. PubMed ID: 21554552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular disease associated with sickle cell pulmonary hypertension.
    Kato GJ; Hsieh M; Machado R; Taylor J; Little J; Butman JA; Lehky T; Tisdale J; Gladwin MT
    Am J Hematol; 2006 Jul; 81(7):503-10. PubMed ID: 16755569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiopulmonary complications in sickle cell anemia].
    Rojas-Jiménez S; Lopera-Valle J; Yabur-Espítia M
    Arch Cardiol Mex; 2013; 83(4):289-94. PubMed ID: 24215682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Sickle Cell Disease in Children.
    Noronha SA; Sadreameli SC; Strouse JJ
    South Med J; 2016 Sep; 109(9):495-502. PubMed ID: 27598348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.